摘要
目的:探讨葛根素联合参脉治疗冠心病心绞痛的疗效。方法:108例确诊为冠心病心绞痛患者随机分为对照组和治疗组。对照组给以参麦注射液60ml加入5%葡萄糖250ml或生理盐水250ml静脉滴注,25滴/min,1次/d,14d为一疗程。治疗组在对照组治疗的基础上加用葛根素500mg+5%葡萄糖溶液500ml静滴,每天1次,疗程14d。结果:治疗组显效23例,有效24例,无效7例,总有效率87%(47/54);对照组显效11例,有效13例,无效30例,总有效率44%(24/54)。结论:葛根素与参脉在治疗冠心病心绞痛中有协同作用,可以在临床推广使用。
Objective: To observe the effect puerarin associated with Shenmai injection in the treatment of patients with angina pectoris of coronary heart disease. Methods: 108 patients with angina pectoris were randomly divided into 2 groups. The contrast group cases received Shenmai injection 60ml plus sodium chlo- ride 250ml,25 drops per rain, ivgtt, qd for 14d;The treatment group cases received both Puerarin injection 500mg plus sodium chloride 500ml, ivgtt, qd for 14d and Shenmai injection as the way in the contrast group. Results:There were 23 cases excellent, 24 cases effective and 7 cases ineffective in the treated group. The total effective rate was 87% (47/54). There were 11 cases excellent, 13 cases effective and 30 cases inef- fective in the contrast group. The total effective rate was 44% (24/54). Conclusion :The puerarin associated with Shenmai injection have a good synergism in the treatment of angina pectoris of coronary heart diseases and it can be used widely in clinical.
出处
《河北医学》
CAS
2008年第10期1201-1203,共3页
Hebei Medicine
关键词
冠心病
治疗
葛根素
参脉
Coronary heart diseases
Treatment
Puerarin
Shenmai